Patent · US Active

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

US10519186B2 · kind B2 · utility

14Cited by
133References
52Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2018
Grant dateDec 31, 2019
Priority date—
Expiry dateApr 29, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A hemi-sulfate salt of the structure: to treat a host infected with hepatitis C, as well as pharmaceutical compositions and dosage forms, including solid dosage forms, thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.